1. Home
  2. TNC vs NVCR Comparison

TNC vs NVCR Comparison

Compare TNC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tennant Company

TNC

Tennant Company

HOLD

Current Price

$73.81

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$13.14

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNC
NVCR
Founded
1870
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
TNC
NVCR
Price
$73.81
$13.14
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$102.00
$28.42
AVG Volume (30 Days)
140.0K
1.5M
Earning Date
02-17-2026
10-30-2025
Dividend Yield
1.68%
N/A
EPS Growth
N/A
N/A
EPS
2.91
N/A
Revenue
$1,240,800,000.00
$642,269,000.00
Revenue This Year
N/A
$9.75
Revenue Next Year
$5.63
$5.62
P/E Ratio
$25.42
N/A
Revenue Growth
N/A
11.17
52 Week Low
$67.32
$10.70
52 Week High
$90.44
$31.17

Technical Indicators

Market Signals
Indicator
TNC
NVCR
Relative Strength Index (RSI) 44.04 54.16
Support Level $73.07 $12.88
Resistance Level $75.87 $13.64
Average True Range (ATR) 1.39 0.47
MACD -0.17 0.00
Stochastic Oscillator 14.29 49.70

Price Performance

Historical Comparison
TNC
NVCR

About TNC Tennant Company

Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: